Significant pharmacokinetic interaction between risperidone and carbamazepine: its relationship with genotypes

Author： Ono Shingo Mihara Kazuo Suzuki Akihito Kondo Tsuyoshi Yasui-Furukori Norio Furukori Hanako de Vries Ronald Kaneko Sunao

Publisher： Springer Publishing Company

ISSN： 0033-3158

Source： Psychopharmacology, Vol.162, Iss.1, 2002-06, pp. : 50-54

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Evaluation of the potential pharmacokinetic interaction of venlafaxine and carbamazepine

By Wiklander B. Danjou P. Rolan P. Tamin S.K. Toon S.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 310-311

Elsevier

Access to resources Recommend Favorite

Pharmacokinetic differences between the enantiomers of lansoprazole and its metabolite, 5-hydroxylansoprazole, in relation to CYP2C19 genotypes

By Miura M. Tada H. Yasui-Furukori N. Uno T. Sugawara K. Tateishi T. Suzuki T.

European Journal of Clinical Pharmacology, Vol. 60, Iss. 9, 2004-11 ,pp. : 623-628

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetic Interaction Between Tacrolimus and Diltiazem: Dose-Response Relationship in Kidney and Liver Transplant Recipients

By Jones T.E.

Clinical Pharmacokinetics, Vol. 41, Iss. 5, 2002-01 ,pp. : 381-388

Adis International

Access to resources Recommend Favorite

Clinically Significant Pharmacokinetic Interactions Between Dietary Caffeine and Medications

By Carrillo J.A. Benitez J.

Clinical Pharmacokinetics, Vol. 39, Iss. 2, 2000-08 ,pp. : 127-153

Adis International

Access to resources Recommend Favorite

Pharmacokinetic interaction trial between co-artemether and mefloquine

By Lefevre G. Bindschedler M. Ezzet F. Schaeffer N. Meyer I. Thomsen M.S.

European Journal of Pharmaceutical Sciences, Vol. 10, Iss. 2, 2000-04 ,pp. : 141-151

Elsevier

Access to resources Recommend Favorite